
Dimerix banks upfront US$30m payment in US pharma licensing deal for kidney drug
Dimerix receives initial payment for DMX-200 under US licensing deal. Pic via Getty Images. Dimerix receives upfront payment of US$30 million for US licensing deal of DMX-200 Company eligible for further potential development milestones of up to US$560 …